$EDIT Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Editas Medicine, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Editas Medicine, Inc.. Get notifications about new insider transactions in Editas Medicine, Inc. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 16 2021 | EDIT | Editas Medicine, I ... | Shearman Mark S | EVP, Chief Scientif ... | Option Exercise | A | 38.53 | 52,718 | 2,031,225 | 52,718 | |
| Jun 16 2021 | EDIT | Editas Medicine, I ... | Shearman Mark S | EVP, Chief Scientif ... | Grant | A | 0.00 | 32,701 | 0 | 32,701 | 0 to 32.7 K |
| Mar 05 2021 | EDIT | Editas Medicine, I ... | Hopfield Jessica | Director | Buy | P | 45.51 | 5,800 | 263,970 | 22,700 | 16.9 K to 22.7 K (+34.32 %) |
| Mar 04 2021 | EDIT | Editas Medicine, I ... | MULLEN JAMES C | CEO | Option Exercise | A | 45.69 | 196,637 | 8,984,345 | 196,637 | |
| Mar 04 2021 | EDIT | Editas Medicine, I ... | MULLEN JAMES C | CEO | Buy | P | 46.27 | 25,000 | 1,156,800 | 35,000 | 10 K to 35 K (+250.00 %) |
| Feb 10 2021 | EDIT | Editas Medicine, I ... | Collins Cynthia | CEO | Sell | S | 66.65 | 1,262 | 84,112 | 43,760 | 45 K to 43.8 K (-2.80 %) |
| Jan 13 2021 | EDIT | Editas Medicine, I ... | ROBERTSON MICHELLE | Chief Financial Off ... | Sell | S | 78.27 | 1,568 | 122,727 | 18,432 | 20 K to 18.4 K (-7.84 %) |
| Dec 18 2020 | EDIT | Editas Medicine, I ... | Chatterjee Meeta | Director | Option Exercise | A | 62.71 | 23,076 | 1,447,096 | 23,076 | |
| Dec 17 2020 | EDIT | Editas Medicine, I ... | Albright Charles | EVP/Chief Scientifi ... | Option Exercise | M | 16.51 | 10,000 | 165,100 | 145,000 | |
| Dec 17 2020 | EDIT | Editas Medicine, I ... | Albright Charles | EVP/Chief Scientifi ... | Sell | S | 64.39 | 200 | 12,878 | 24,907 | 25.1 K to 24.9 K (-0.80 %) |
| Dec 17 2020 | EDIT | Editas Medicine, I ... | Albright Charles | EVP/Chief Scientifi ... | Sell | S | 63.84 | 4,024 | 256,892 | 25,107 | 29.1 K to 25.1 K (-13.81 %) |
| Dec 17 2020 | EDIT | Editas Medicine, I ... | Albright Charles | EVP/Chief Scientifi ... | Sell | S | 62.74 | 5,776 | 362,386 | 29,131 | 34.9 K to 29.1 K (-16.55 %) |
| Dec 17 2020 | EDIT | Editas Medicine, I ... | Albright Charles | EVP/Chief Scientifi ... | Buy | M | 16.51 | 10,000 | 165,100 | 34,907 | 24.9 K to 34.9 K (+40.15 %) |
| Dec 11 2020 | EDIT | Editas Medicine, I ... | Albright Charles | EVP/Chief Scientifi ... | Option Exercise | M | 16.51 | 10,000 | 165,100 | 155,000 | |
| Dec 11 2020 | EDIT | Editas Medicine, I ... | Albright Charles | EVP/Chief Scientifi ... | Sell | S | 45.00 | 10,000 | 450,000 | 24,907 | 34.9 K to 24.9 K (-28.65 %) |
| Dec 11 2020 | EDIT | Editas Medicine, I ... | Albright Charles | EVP/Chief Scientifi ... | Buy | M | 16.51 | 10,000 | 165,100 | 34,907 | 24.9 K to 34.9 K (+40.15 %) |
| Dec 08 2020 | EDIT | Editas Medicine, I ... | Albright Charles | EVP/Chief Scientifi ... | Option Exercise | M | 16.51 | 20,000 | 330,200 | 165,000 | |
| Dec 08 2020 | EDIT | Editas Medicine, I ... | Albright Charles | EVP/Chief Scientifi ... | Sell | S | 40.02 | 20,000 | 800,400 | 24,907 | 44.9 K to 24.9 K (-44.54 %) |
| Dec 08 2020 | EDIT | Editas Medicine, I ... | Albright Charles | EVP/Chief Scientifi ... | Buy | M | 16.51 | 20,000 | 330,200 | 44,907 | 24.9 K to 44.9 K (+80.30 %) |
| Nov 10 2020 | EDIT | Editas Medicine, I ... | Michaels Lisa Anne | EVP/Chief Medical O ... | Option Exercise | A | 30.41 | 120,000 | 3,649,200 | 120,000 | |
| Nov 10 2020 | EDIT | Editas Medicine, I ... | Michaels Lisa Anne | EVP/Chief Medical O ... | Grant | A | 0.00 | 20,000 | 0 | 20,000 | 0 to 20 K |
| Nov 10 2020 | EDIT | Editas Medicine, I ... | Albright Charles | EVP/Chief Scientifi ... | Sell | S | 31.21 | 228 | 7,116 | 24,907 | 25.1 K to 24.9 K (-0.91 %) |
| Oct 16 2020 | EDIT | Editas Medicine, I ... | Albright Charles | EVP/Chief Scientifi ... | Sell | S | 31.39 | 3,000 | 94,170 | 25,135 | 28.1 K to 25.1 K (-10.66 %) |
| Aug 21 2020 | EDIT | Editas Medicine, I ... | Collins Cynthia | CEO | Sell | S | 36.66 | 1,976 | 72,440 | 45,022 | 47 K to 45 K (-4.20 %) |
| Aug 19 2020 | EDIT | Editas Medicine, I ... | Albright Charles | EVP/Chief Scientifi ... | Option Exercise | M | 16.51 | 10,000 | 165,100 | 185,000 | |
| Aug 19 2020 | EDIT | Editas Medicine, I ... | Albright Charles | EVP/Chief Scientifi ... | Sell | S | 35.29 | 10,000 | 352,900 | 28,135 | 38.1 K to 28.1 K (-26.22 %) |
| Aug 19 2020 | EDIT | Editas Medicine, I ... | Albright Charles | EVP/Chief Scientifi ... | Buy | M | 16.51 | 10,000 | 165,100 | 38,135 | 28.1 K to 38.1 K (+35.54 %) |
| Aug 19 2020 | EDIT | Editas Medicine, I ... | Albright Charles | EVP/Chief Scientifi ... | Option Exercise | M | 16.51 | 10,000 | 165,100 | 185,000 | |
| Aug 19 2020 | EDIT | Editas Medicine, I ... | Albright Charles | EVP/Chief Scientifi ... | Sell | S | 35.29 | 10,000 | 352,900 | 28,135 | 38.1 K to 28.1 K (-26.22 %) |
| Aug 19 2020 | EDIT | Editas Medicine, I ... | Albright Charles | EVP/Chief Scientifi ... | Buy | M | 16.51 | 10,000 | 165,100 | 38,135 | 28.1 K to 38.1 K (+35.54 %) |
| Aug 10 2020 | EDIT | Editas Medicine, I ... | Albright Charles | EVP/Chief Scientifi ... | Option Exercise | M | 16.51 | 10,000 | 165,100 | 195,000 | |
| Aug 10 2020 | EDIT | Editas Medicine, I ... | Albright Charles | EVP/Chief Scientifi ... | Sell | S | 34.99 | 238 | 8,328 | 28,135 | 28.4 K to 28.1 K (-0.84 %) |
| Aug 10 2020 | EDIT | Editas Medicine, I ... | Albright Charles | EVP/Chief Scientifi ... | Sell | S | 37.47 | 10,000 | 374,700 | 28,373 | 38.4 K to 28.4 K (-26.06 %) |
| Aug 10 2020 | EDIT | Editas Medicine, I ... | Albright Charles | EVP/Chief Scientifi ... | Buy | M | 16.51 | 10,000 | 165,100 | 38,373 | 28.4 K to 38.4 K (+35.24 %) |
| Jul 17 2020 | EDIT | Editas Medicine, I ... | Albright Charles | EVP/Chief Scientifi ... | Sell | S | 32.22 | 3,000 | 96,660 | 28,373 | 31.4 K to 28.4 K (-9.56 %) |
| Jun 12 2020 | EDIT | Editas Medicine, I ... | MULLEN JAMES C | Director | Option Exercise | A | 27.49 | 11,538 | 317,180 | 11,538 | |
| Jun 12 2020 | EDIT | Editas Medicine, I ... | Hopfield Jessica | Director | Option Exercise | A | 27.49 | 11,538 | 317,180 | 11,538 | |
| Jun 12 2020 | EDIT | Editas Medicine, I ... | Hirsch Andrew | Director | Option Exercise | A | 27.49 | 11,538 | 317,180 | 11,538 | |
| Jun 12 2020 | EDIT | Editas Medicine, I ... | Scadden David | Director | Option Exercise | A | 27.49 | 11,538 | 317,180 | 11,538 | |
| May 08 2020 | EDIT | Editas Medicine, I ... | Albright Charles | EVP/Chief Scientifi ... | Sell | S | 25.28 | 151 | 3,817 | 31,373 | 31.5 K to 31.4 K (-0.48 %) |
| Feb 10 2020 | EDIT | Editas Medicine, I ... | Albright Charles | Chief Scientific Of ... | Option Exercise | A | 28.05 | 69,556 | 1,951,046 | 69,556 | |
| Feb 10 2020 | EDIT | Editas Medicine, I ... | Albright Charles | Chief Scientific Of ... | Sell | S | 26.95 | 622 | 16,763 | 31,524 | 32.1 K to 31.5 K (-1.93 %) |
| Feb 10 2020 | EDIT | Editas Medicine, I ... | Albright Charles | Chief Scientific Of ... | Grant | A | 0.00 | 11,593 | 0 | 32,146 | 20.6 K to 32.1 K (+56.41 %) |
| Feb 10 2020 | EDIT | Editas Medicine, I ... | Collins Cynthia | CEO | Option Exercise | A | 28.05 | 93,750 | 2,629,688 | 93,750 | |
| Feb 10 2020 | EDIT | Editas Medicine, I ... | Collins Cynthia | CEO | Grant | A | 0.00 | 15,625 | 0 | 46,998 | 31.4 K to 47 K (+49.80 %) |
| Feb 04 2020 | EDIT | Editas Medicine, I ... | Albright Charles | Chief Scientific Of ... | Option Exercise | M | 0.00 | 17,977 | 0 | 0 | |
| Feb 04 2020 | EDIT | Editas Medicine, I ... | Albright Charles | Chief Scientific Of ... | Sell | S | 26.54 | 5,549 | 147,288 | 20,553 | 26.1 K to 20.6 K (-21.26 %) |
| Feb 04 2020 | EDIT | Editas Medicine, I ... | Albright Charles | Chief Scientific Of ... | Buy | M | 0.00 | 17,977 | 0 | 26,102 | 8.1 K to 26.1 K (+221.26 %) |
| Jan 10 2020 | EDIT | Editas Medicine, I ... | ROBERTSON MICHELLE | Chief Financial Off ... | Option Exercise | A | 30.65 | 120,000 | 3,678,000 | 120,000 | |
| Jan 10 2020 | EDIT | Editas Medicine, I ... | ROBERTSON MICHELLE | Chief Financial Off ... | Grant | A | 0.00 | 20,000 | 0 | 20,000 | 0 to 20 K |
| Oct 30 2019 | EDIT | Editas Medicine, I ... | Abrams Judith R | Chief Medical Offic ... | Option Exercise | A | 21.61 | 150,000 | 3,241,500 | 150,000 | |
| Oct 30 2019 | EDIT | Editas Medicine, I ... | Abrams Judith R | Chief Medical Offic ... | Grant | A | 0.00 | 25,000 | 0 | 25,000 | 0 to 25 K |
| Sep 13 2019 | EDIT | Editas Medicine, I ... | Collins Cynthia | CEO | Option Exercise | A | 26.57 | 250,000 | 6,642,500 | 250,000 | |
| Sep 13 2019 | EDIT | Editas Medicine, I ... | Collins Cynthia | CEO | Option Exercise | A | 26.57 | 500,000 | 13,285,000 | 500,000 | |
| Sep 13 2019 | EDIT | Editas Medicine, I ... | Collins Cynthia | CEO | Grant | A | 0.00 | 20,000 | 0 | 31,373 | 11.4 K to 31.4 K (+175.86 %) |
| Aug 21 2019 | EDIT | Editas Medicine, I ... | Collins Cynthia | CEO | Sell | S | 25.83 | 5,193 | 134,135 | 11,373 | 16.6 K to 11.4 K (-31.35 %) |
| Aug 21 2019 | EDIT | Editas Medicine, I ... | Collins Cynthia | CEO | Grant | A | 0.00 | 8,283 | 0 | 16,566 | 8.3 K to 16.6 K (+100.00 %) |
| Aug 07 2019 | EDIT | Editas Medicine, I ... | Collins Cynthia | CEO | Grant | A | 0.00 | 8,283 | 0 | 16,566 | 8.3 K to 16.6 K (+100.00 %) |
| Jun 14 2019 | EDIT | Editas Medicine, I ... | Hirsch Andrew | Director | Option Exercise | A | 21.74 | 11,538 | 250,836 | 11,538 | |
| Jun 14 2019 | EDIT | Editas Medicine, I ... | Hopfield Jessica | Director | Option Exercise | A | 21.74 | 11,538 | 250,836 | 11,538 | |
| Jun 14 2019 | EDIT | Editas Medicine, I ... | MULLEN JAMES C | Director | Option Exercise | A | 21.74 | 11,538 | 250,836 | 11,538 | |
| Jun 14 2019 | EDIT | Editas Medicine, I ... | Vaishnaw Akshay | Director | Option Exercise | A | 21.74 | 11,538 | 250,836 | 11,538 | |
| Jun 14 2019 | EDIT | Editas Medicine, I ... | Collins Cynthia | Interim CEO | Option Exercise | A | 21.74 | 11,538 | 250,836 | 11,538 | |
| Mar 20 2019 | EDIT | Editas Medicine, I ... | Myer Vickesh | Chief Technology Of ... | Option Exercise | M | 0.65 | 3,000 | 1,950 | 73,307 | |
| Mar 20 2019 | EDIT | Editas Medicine, I ... | Myer Vickesh | Chief Technology Of ... | Sell | S | 24.50 | 3,000 | 73,500 | 0 | 3 K to 0 (-100.00 %) |
| Mar 20 2019 | EDIT | Editas Medicine, I ... | Myer Vickesh | Chief Technology Of ... | Buy | M | 0.65 | 3,000 | 1,950 | 3,000 | 0 to 3 K |
| Mar 07 2019 | EDIT | Editas Medicine, I ... | Hopfield Jessica | Director | Buy | P | 23.94 | 10,200 | 244,188 | 16,900 | 6.7 K to 16.9 K (+152.24 %) |
| Feb 22 2019 | EDIT | Editas Medicine, I ... | Myer Vickesh | Chief Technology Of ... | Option Exercise | M | 0.65 | 3,000 | 1,950 | 76,307 | |
| Feb 22 2019 | EDIT | Editas Medicine, I ... | Myer Vickesh | Chief Technology Of ... | Sell | S | 20.42 | 3,000 | 61,260 | 0 | 3 K to 0 (-100.00 %) |
| Feb 22 2019 | EDIT | Editas Medicine, I ... | Myer Vickesh | Chief Technology Of ... | Buy | M | 0.65 | 3,000 | 1,950 | 3,000 | 0 to 3 K |
| Feb 08 2019 | EDIT | Editas Medicine, I ... | Albright Charles | Chief Scientific Of ... | Option Exercise | A | 0.00 | 8,125 | 0 | 8,125 | |
| Feb 08 2019 | EDIT | Editas Medicine, I ... | Albright Charles | Chief Scientific Of ... | Option Exercise | A | 21.10 | 48,750 | 1,028,625 | 48,750 | |
| Feb 08 2019 | EDIT | Editas Medicine, I ... | Myer Vickesh | Chief Technology Of ... | Option Exercise | A | 0.00 | 8,125 | 0 | 8,125 | |
| Feb 08 2019 | EDIT | Editas Medicine, I ... | Myer Vickesh | Chief Technology Of ... | Option Exercise | A | 21.10 | 48,750 | 1,028,625 | 48,750 | |
| Feb 07 2019 | EDIT | Editas Medicine, I ... | Scadden David | Director | Option Exercise | A | 21.14 | 23,076 | 487,827 | 23,076 | |
| Feb 06 2019 | EDIT | Editas Medicine, I ... | Hack Andrew A. F. | Chief Financial Off ... | Option Exercise | M | 6.48 | 6,895 | 44,680 | 9,618 | |
| Feb 06 2019 | EDIT | Editas Medicine, I ... | Hack Andrew A. F. | Chief Financial Off ... | Sell | S | 21.39 | 6,895 | 147,484 | 0 | 6.9 K to 0 (-100.00 %) |
| Feb 06 2019 | EDIT | Editas Medicine, I ... | Hack Andrew A. F. | Chief Financial Off ... | Buy | M | 6.48 | 6,895 | 44,680 | 6,895 | 0 to 6.9 K |
| Feb 06 2019 | EDIT | Editas Medicine, I ... | Hack Andrew A. F. | Chief Financial Off ... | Option Exercise | M | 6.48 | 6,895 | 44,680 | 9,618 | |
| Feb 06 2019 | EDIT | Editas Medicine, I ... | Hack Andrew A. F. | Chief Financial Off ... | Sell | S | 21.39 | 6,895 | 147,484 | 0 | 6.9 K to 0 (-100.00 %) |
| Feb 06 2019 | EDIT | Editas Medicine, I ... | Hack Andrew A. F. | Chief Financial Off ... | Buy | M | 6.48 | 6,895 | 44,680 | 6,895 | 0 to 6.9 K |
| Feb 04 2019 | EDIT | Editas Medicine, I ... | Collins Cynthia | Director | Option Exercise | A | 0.00 | 8,283 | 0 | 8,283 | |
| Feb 04 2019 | EDIT | Editas Medicine, I ... | Myer Vickesh | Chief Technology Of ... | Option Exercise | A | 0.00 | 16,722 | 0 | 16,722 | |
| Feb 04 2019 | EDIT | Editas Medicine, I ... | Albright Charles | Chief Scientific Of ... | Option Exercise | A | 0.00 | 17,977 | 0 | 17,977 | |
| Jan 18 2019 | EDIT | Editas Medicine, I ... | Myer Vickesh | Chief Technology Of ... | Option Exercise | M | 11.21 | 4,000 | 44,840 | 52,897 | |
| Jan 18 2019 | EDIT | Editas Medicine, I ... | Myer Vickesh | Chief Technology Of ... | Option Exercise | M | 0.65 | 3,000 | 1,950 | 79,307 | |
| Jan 18 2019 | EDIT | Editas Medicine, I ... | Myer Vickesh | Chief Technology Of ... | Sell | S | 26.50 | 4,000 | 106,000 | 0 | 4 K to 0 (-100.00 %) |
| Jan 18 2019 | EDIT | Editas Medicine, I ... | Myer Vickesh | Chief Technology Of ... | Buy | M | 11.21 | 4,000 | 44,840 | 4,000 | 0 to 4 K |
| Jan 18 2019 | EDIT | Editas Medicine, I ... | Myer Vickesh | Chief Technology Of ... | Sell | S | 26.18 | 3,000 | 78,540 | 0 | 3 K to 0 (-100.00 %) |
| Jan 18 2019 | EDIT | Editas Medicine, I ... | Myer Vickesh | Chief Technology Of ... | Buy | M | 0.65 | 3,000 | 1,950 | 3,000 | 0 to 3 K |
| Jan 10 2019 | EDIT | Editas Medicine, I ... | Bosley Katrine | President and CEO | Sell | S | 25.27 | 12,000 | 303,240 | 1,204,966 | 1.2 M to 1.2 M (-0.99 %) |
| Jan 08 2019 | EDIT | Editas Medicine, I ... | Hack Andrew A. F. | Chief Financial Off ... | Option Exercise | M | 6.48 | 7,000 | 45,360 | 16,513 | |
| Jan 08 2019 | EDIT | Editas Medicine, I ... | Hack Andrew A. F. | Chief Financial Off ... | Sell | S | 22.48 | 7,000 | 157,360 | 0 | 7 K to 0 (-100.00 %) |
| Jan 08 2019 | EDIT | Editas Medicine, I ... | Hack Andrew A. F. | Chief Financial Off ... | Buy | M | 6.48 | 7,000 | 45,360 | 7,000 | 0 to 7 K |
| Dec 19 2018 | EDIT | Editas Medicine, I ... | Myer Vickesh | Chief Technology Of ... | Option Exercise | M | 11.21 | 4,000 | 44,840 | 56,897 | |
| Dec 19 2018 | EDIT | Editas Medicine, I ... | Myer Vickesh | Chief Technology Of ... | Option Exercise | M | 0.65 | 3,000 | 1,950 | 82,307 | |
| Dec 19 2018 | EDIT | Editas Medicine, I ... | Myer Vickesh | Chief Technology Of ... | Sell | S | 27.41 | 4,000 | 109,640 | 0 | 4 K to 0 (-100.00 %) |
| Dec 19 2018 | EDIT | Editas Medicine, I ... | Myer Vickesh | Chief Technology Of ... | Buy | M | 11.21 | 4,000 | 44,840 | 4,000 | 0 to 4 K |
| Dec 19 2018 | EDIT | Editas Medicine, I ... | Myer Vickesh | Chief Technology Of ... | Sell | S | 28.34 | 700 | 19,838 | 0 | 700 to 0 (-100.00 %) |
| Dec 19 2018 | EDIT | Editas Medicine, I ... | Myer Vickesh | Chief Technology Of ... | Sell | S | 27.75 | 2,300 | 63,825 | 700 | 3 K to 700 (-76.67 %) |
| Dec 19 2018 | EDIT | Editas Medicine, I ... | Myer Vickesh | Chief Technology Of ... | Buy | M | 0.65 | 3,000 | 1,950 | 3,000 | 0 to 3 K |
| Dec 10 2018 | EDIT | Editas Medicine, I ... | Collins Cynthia | Director | Option Exercise | A | 29.69 | 23,076 | 685,126 | 23,076 | |
| Dec 06 2018 | EDIT | Editas Medicine, I ... | Bosley Katrine | President and CEO | Sell | S | 32.39 | 100 | 3,239 | 1,216,966 | 1.2 M to 1.2 M (-0.01 %) |
| Dec 06 2018 | EDIT | Editas Medicine, I ... | Bosley Katrine | President and CEO | Sell | S | 31.92 | 11,900 | 379,848 | 1,217,066 | 1.2 M to 1.2 M (-0.97 %) |
| Nov 27 2018 | EDIT | Editas Medicine, I ... | Hack Andrew A. F. | Chief Financial Off ... | Option Exercise | M | 6.48 | 5,284 | 34,240 | 12,229 | |
| Nov 27 2018 | EDIT | Editas Medicine, I ... | Hack Andrew A. F. | Chief Financial Off ... | Sell | S | 28.61 | 100 | 2,861 | 0 | 100 to 0 (-100.00 %) |
| Nov 27 2018 | EDIT | Editas Medicine, I ... | Hack Andrew A. F. | Chief Financial Off ... | Sell | S | 28.14 | 5,184 | 145,878 | 100 | 5.3 K to 100 (-98.11 %) |
| Nov 27 2018 | EDIT | Editas Medicine, I ... | Hack Andrew A. F. | Chief Financial Off ... | Buy | M | 6.48 | 5,284 | 34,240 | 5,284 | 0 to 5.3 K |
| Nov 21 2018 | EDIT | Editas Medicine, I ... | Myer Vickesh | Chief Technology Of ... | Option Exercise | M | 11.21 | 4,000 | 44,840 | 60,897 | |
| Nov 21 2018 | EDIT | Editas Medicine, I ... | Myer Vickesh | Chief Technology Of ... | Option Exercise | M | 0.65 | 3,000 | 1,950 | 85,307 | |
| Nov 21 2018 | EDIT | Editas Medicine, I ... | Myer Vickesh | Chief Technology Of ... | Sell | S | 26.50 | 4,000 | 106,000 | 0 | 4 K to 0 (-100.00 %) |
| Nov 21 2018 | EDIT | Editas Medicine, I ... | Myer Vickesh | Chief Technology Of ... | Buy | M | 11.21 | 4,000 | 44,840 | 4,000 | 0 to 4 K |
| Nov 21 2018 | EDIT | Editas Medicine, I ... | Myer Vickesh | Chief Technology Of ... | Sell | S | 28.85 | 300 | 8,655 | 0 | 300 to 0 (-100.00 %) |
| Nov 21 2018 | EDIT | Editas Medicine, I ... | Myer Vickesh | Chief Technology Of ... | Buy | M | 0.65 | 300 | 195 | 300 | 0 to 300 |
| Nov 21 2018 | EDIT | Editas Medicine, I ... | Myer Vickesh | Chief Technology Of ... | Sell | S | 28.12 | 2,700 | 75,924 | 0 | 2.7 K to 0 (-100.00 %) |
| Nov 21 2018 | EDIT | Editas Medicine, I ... | Myer Vickesh | Chief Technology Of ... | Buy | M | 0.65 | 2,700 | 1,755 | 2,700 | 0 to 2.7 K |
| Nov 05 2018 | EDIT | Editas Medicine, I ... | Bosley Katrine | President and CEO | Sell | S | 27.21 | 8,600 | 234,006 | 1,228,966 | 1.2 M to 1.2 M (-0.69 %) |
| Nov 05 2018 | EDIT | Editas Medicine, I ... | Bosley Katrine | President and CEO | Sell | S | 26.03 | 3,400 | 88,502 | 1,237,566 | 1.2 M to 1.2 M (-0.27 %) |
| Oct 30 2018 | EDIT | Editas Medicine, I ... | Hack Andrew A. F. | Chief Financial Off ... | Option Exercise | M | 6.48 | 6,000 | 38,880 | 17,513 | |
| Oct 30 2018 | EDIT | Editas Medicine, I ... | Hack Andrew A. F. | Chief Financial Off ... | Sell | S | 25.70 | 6,000 | 154,200 | 0 | 6 K to 0 (-100.00 %) |
| Oct 30 2018 | EDIT | Editas Medicine, I ... | Hack Andrew A. F. | Chief Financial Off ... | Buy | M | 6.48 | 6,000 | 38,880 | 6,000 | 0 to 6 K |
| Oct 19 2018 | EDIT | Editas Medicine, I ... | Myer Vickesh | Chief Technology Of ... | Option Exercise | M | 11.21 | 4,000 | 44,840 | 64,897 | |
| Oct 19 2018 | EDIT | Editas Medicine, I ... | Myer Vickesh | Chief Technology Of ... | Option Exercise | M | 0.65 | 3,000 | 1,950 | 88,307 | |
| Oct 19 2018 | EDIT | Editas Medicine, I ... | Myer Vickesh | Chief Technology Of ... | Sell | S | 29.44 | 4,000 | 117,760 | 0 | 4 K to 0 (-100.00 %) |
| Oct 19 2018 | EDIT | Editas Medicine, I ... | Myer Vickesh | Chief Technology Of ... | Buy | M | 11.21 | 4,000 | 44,840 | 4,000 | 0 to 4 K |
| Oct 19 2018 | EDIT | Editas Medicine, I ... | Myer Vickesh | Chief Technology Of ... | Sell | S | 28.87 | 3,000 | 86,610 | 0 | 3 K to 0 (-100.00 %) |
| Oct 19 2018 | EDIT | Editas Medicine, I ... | Myer Vickesh | Chief Technology Of ... | Buy | M | 0.65 | 3,000 | 1,950 | 3,000 | 0 to 3 K |
| Oct 03 2018 | EDIT | Editas Medicine, I ... | Bosley Katrine | President and CEO | Sell | S | 31.44 | 5,766 | 181,283 | 1,240,966 | 1.2 M to 1.2 M (-0.46 %) |
| Oct 03 2018 | EDIT | Editas Medicine, I ... | Bosley Katrine | President and CEO | Sell | S | 30.64 | 6,234 | 191,010 | 1,246,732 | 1.3 M to 1.2 M (-0.50 %) |
| Oct 02 2018 | EDIT | Editas Medicine, I ... | Hack Andrew A. F. | Chief Financial Off ... | Option Exercise | M | 6.48 | 8,000 | 51,840 | 23,513 | |
| Oct 02 2018 | EDIT | Editas Medicine, I ... | Hack Andrew A. F. | Chief Financial Off ... | Sell | S | 32.08 | 8,000 | 256,640 | 0 | 8 K to 0 (-100.00 %) |
| Oct 02 2018 | EDIT | Editas Medicine, I ... | Hack Andrew A. F. | Chief Financial Off ... | Buy | M | 6.48 | 8,000 | 51,840 | 8,000 | 0 to 8 K |
| Sep 19 2018 | EDIT | Editas Medicine, I ... | Myer Vickesh | Chief Technology Of ... | Option Exercise | M | 11.21 | 4,000 | 44,840 | 68,897 | |
| Sep 19 2018 | EDIT | Editas Medicine, I ... | Myer Vickesh | Chief Technology Of ... | Option Exercise | M | 0.65 | 3,000 | 1,950 | 91,307 | |
| Sep 19 2018 | EDIT | Editas Medicine, I ... | Myer Vickesh | Chief Technology Of ... | Sell | S | 32.19 | 4,000 | 128,760 | 0 | 4 K to 0 (-100.00 %) |
| Sep 19 2018 | EDIT | Editas Medicine, I ... | Myer Vickesh | Chief Technology Of ... | Buy | M | 11.21 | 4,000 | 44,840 | 4,000 | 0 to 4 K |
| Sep 19 2018 | EDIT | Editas Medicine, I ... | Myer Vickesh | Chief Technology Of ... | Sell | S | 32.33 | 3,000 | 96,990 | 0 | 3 K to 0 (-100.00 %) |
| Sep 19 2018 | EDIT | Editas Medicine, I ... | Myer Vickesh | Chief Technology Of ... | Buy | M | 0.65 | 3,000 | 1,950 | 3,000 | 0 to 3 K |
| Sep 06 2018 | EDIT | Editas Medicine, I ... | Bosley Katrine | President and CEO | Sell | S | 33.07 | 1,213 | 40,114 | 1,252,966 | 1.3 M to 1.3 M (-0.10 %) |
| Sep 06 2018 | EDIT | Editas Medicine, I ... | Bosley Katrine | President and CEO | Sell | S | 32.27 | 10,787 | 348,096 | 1,254,179 | 1.3 M to 1.3 M (-0.85 %) |
| Sep 05 2018 | EDIT | Editas Medicine, I ... | Hack Andrew A. F. | Chief Financial Off ... | Option Exercise | M | 6.48 | 10,000 | 64,800 | 31,513 | |
| Sep 05 2018 | EDIT | Editas Medicine, I ... | Hack Andrew A. F. | Chief Financial Off ... | Sell | S | 32.23 | 10,000 | 322,300 | 0 | 10 K to 0 (-100.00 %) |
| Sep 05 2018 | EDIT | Editas Medicine, I ... | Hack Andrew A. F. | Chief Financial Off ... | Buy | M | 6.48 | 10,000 | 64,800 | 10,000 | 0 to 10 K |
| Aug 22 2018 | EDIT | Editas Medicine, I ... | Bosley Katrine | President and CEO | Sell | S | 30.43 | 5,433 | 165,326 | 1,264,966 | 1.3 M to 1.3 M (-0.43 %) |
| Aug 22 2018 | EDIT | Editas Medicine, I ... | Bosley Katrine | President and CEO | Sell | S | 29.95 | 6,567 | 196,682 | 1,270,399 | 1.3 M to 1.3 M (-0.51 %) |
| Aug 21 2018 | EDIT | Editas Medicine, I ... | Myer Vickesh | Chief Technology Of ... | Option Exercise | M | 11.21 | 4,000 | 44,840 | 72,897 | |
| Aug 21 2018 | EDIT | Editas Medicine, I ... | Myer Vickesh | Chief Technology Of ... | Option Exercise | M | 0.65 | 3,000 | 1,950 | 94,307 | |
| Aug 21 2018 | EDIT | Editas Medicine, I ... | Myer Vickesh | Chief Technology Of ... | Sell | S | 30.41 | 400 | 12,164 | 0 | 400 to 0 (-100.00 %) |
| Aug 21 2018 | EDIT | Editas Medicine, I ... | Myer Vickesh | Chief Technology Of ... | Buy | M | 11.21 | 400 | 4,484 | 400 | 0 to 400 |
| Aug 21 2018 | EDIT | Editas Medicine, I ... | Myer Vickesh | Chief Technology Of ... | Sell | S | 29.81 | 3,600 | 107,316 | 0 | 3.6 K to 0 (-100.00 %) |